72934-4146 NDC - MINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Drug Information

Product NDC: 72934-4146

Proprietary Name: MINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Non Proprietary Name: MINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Active Ingredient(s):
  • 5 g/100g MINOXIDIL;
  • .1 g/100g PROGESTERONE;
  • .025 g/100g TRETINOIN


Administration Route(s): TOPICAL

Dosage Form(s): SOLUTION

Pharmacy Class(es):
  • Arteriolar Vasodilation [PE];
  • Arteriolar Vasodilator [EPC];
  • Progesterone [CS];
  • Progesterone [EPC];
  • Retinoid [EPC];
  • Retinoids [CS]

Labeler Information

Labeler Name: Sincerus Florida, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:5/7/2019

Package Information

No. Package Code Package Description Billing Unit
172934-4146-860 g in 1 BOTTLE, GLASS (72934-4146-8)

NDC Record

Field Name Field Value Definition
PRODUCT NDC72934-4146The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEMINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEMINOXIDIL 5% / PROGESTERONE 0.1% / TRETINOIN 0.025%The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/7/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMESincerus Florida, LLCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEMINOXIDIL; PROGESTERONE; TRETINOINThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH5; .1; .025 
ACTIVE INGRED UNITg/100g; g/100g; g/100g 
PHARM CLASSESArteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC],Progesterone [CS],Progesterone [EPC],Retinoid [EPC],Retinoids [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 9/11/2020